Logo image of SMLR

SEMLER SCIENTIFIC INC (SMLR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SMLR - US81684M1045 - Common Stock

19.77 USD
+1.1 (+5.89%)
Last: 12/8/2025, 6:43:36 PM
19.62 USD
-0.15 (-0.76%)
After Hours: 12/8/2025, 6:43:36 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SMLR. SMLR was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While SMLR is still in line with the averages on profitability rating, there are concerns on its financial health. SMLR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

SMLR had positive earnings in the past year.
In the past year SMLR has reported a negative cash flow from operations.
SMLR had positive earnings in each of the past 5 years.
In the past 5 years SMLR always reported a positive cash flow from operatings.
SMLR Yearly Net Income VS EBIT VS OCF VS FCFSMLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of 8.10%, SMLR belongs to the top of the industry, outperforming 89.30% of the companies in the same industry.
With an excellent Return On Equity value of 10.51%, SMLR belongs to the best of the industry, outperforming 87.17% of the companies in the same industry.
Industry RankSector Rank
ROA 8.1%
ROE 10.51%
ROIC N/A
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)N/A
ROIC(5y)N/A
SMLR Yearly ROA, ROE, ROICSMLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600 800 1K

1.3 Margins

SMLR's Profit Margin of 130.80% is amongst the best of the industry. SMLR outperforms 99.47% of its industry peers.
SMLR's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of SMLR has grown nicely.
SMLR's Gross Margin of 90.83% is amongst the best of the industry. SMLR outperforms 97.33% of its industry peers.
SMLR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 130.8%
GM 90.83%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
SMLR Yearly Profit, Operating, Gross MarginsSMLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

SMLR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SMLR has been increased compared to 1 year ago.
Compared to 5 years ago, SMLR has more shares outstanding
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SMLR Yearly Shares OutstandingSMLR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
SMLR Yearly Total Debt VS Total AssetsSMLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of 1.61, we must say that SMLR is in the distress zone and has some risk of bankruptcy.
SMLR has a Altman-Z score of 1.61. This is comparable to the rest of the industry: SMLR outperforms 56.68% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that SMLR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.25, SMLR is in line with its industry, outperforming 55.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 1.61
ROIC/WACCN/A
WACC8.78%
SMLR Yearly LT Debt VS Equity VS FCFSMLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.97 indicates that SMLR should not have too much problems paying its short term obligations.
SMLR's Current ratio of 1.97 is on the low side compared to the rest of the industry. SMLR is outperformed by 63.64% of its industry peers.
A Quick Ratio of 1.95 indicates that SMLR should not have too much problems paying its short term obligations.
SMLR's Quick ratio of 1.95 is in line compared to the rest of the industry. SMLR outperforms 51.87% of its industry peers.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.95
SMLR Yearly Current Assets VS Current LiabilitesSMLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

SMLR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 220.88%, which is quite impressive.
The Earnings Per Share has been growing by 24.17% on average over the past years. This is a very strong growth
Looking at the last year, SMLR shows a very negative growth in Revenue. The Revenue has decreased by -37.30% in the last year.
Measured over the past years, SMLR shows a quite strong growth in Revenue. The Revenue has been growing by 11.43% on average per year.
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
Revenue 1Y (TTM)-37.3%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%

3.2 Future

SMLR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -29.01% yearly.
SMLR is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -16.29% yearly.
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue Next Year-43.2%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SMLR Yearly Revenue VS EstimatesSMLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
SMLR Yearly EPS VS EstimatesSMLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 2.26, which indicates a rather cheap valuation of SMLR.
Compared to the rest of the industry, the Price/Earnings ratio of SMLR indicates a rather cheap valuation: SMLR is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.34. SMLR is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 242.28, the valuation of SMLR can be described as expensive.
65.24% of the companies in the same industry are more expensive than SMLR, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.56, SMLR is valued quite expensively.
Industry RankSector Rank
PE 2.26
Fwd PE 242.28
SMLR Price Earnings VS Forward Price EarningsSMLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SMLR Per share dataSMLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The decent profitability rating of SMLR may justify a higher PE ratio.
A cheap valuation may be justified as SMLR's earnings are expected to decrease with -29.01% in the coming years.
PEG (NY)N/A
PEG (5Y)0.09
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SMLR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEMLER SCIENTIFIC INC

NASDAQ:SMLR (12/8/2025, 6:43:36 PM)

After market: 19.62 -0.15 (-0.76%)

19.77

+1.1 (+5.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)02-16 2026-02-16
Inst Owners66.43%
Inst Owner Change5.64%
Ins Owners4.79%
Ins Owner Change0.32%
Market Cap299.71M
Revenue(TTM)36.96M
Net Income(TTM)48.34M
Analysts82.22
Price Target66.98 (238.8%)
Short Float %16.53%
Short Ratio1.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1964.05%
Min EPS beat(2)1930.07%
Max EPS beat(2)1998.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.59%
Min Revenue beat(2)-6.63%
Max Revenue beat(2)-0.56%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.83%
PT rev (3m)-23.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)157.14%
EPS NY rev (1m)0%
EPS NY rev (3m)107.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16.33%
Revenue NY rev (1m)0.61%
Revenue NY rev (3m)-3.75%
Valuation
Industry RankSector Rank
PE 2.26
Fwd PE 242.28
P/S 8.11
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB N/A
EV/EBITDA N/A
EPS(TTM)8.76
EY44.31%
EPS(NY)0.08
Fwd EY0.41%
FCF(TTM)-1.79
FCFYN/A
OCF(TTM)-1.78
OCFYN/A
SpS2.44
BVpS30.33
TBVpS-5.28
PEG (NY)N/A
PEG (5Y)0.09
Graham Number77.31
Profitability
Industry RankSector Rank
ROA 8.1%
ROE 10.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 130.8%
GM 90.83%
FCFM N/A
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score2
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.77%
Cap/Sales 0.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.97
Quick Ratio 1.95
Altman-Z 1.61
F-Score2
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-37.3%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%
Revenue Next Year-43.2%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
EBIT growth 1Y-126.25%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year-354.87%
EBIT Next 3Y-51.48%
EBIT Next 5YN/A
FCF growth 1Y-262.46%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y-244.7%
OCF growth 3Y14.98%
OCF growth 5Y13.91%

SEMLER SCIENTIFIC INC / SMLR FAQ

What is the ChartMill fundamental rating of SEMLER SCIENTIFIC INC (SMLR) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SMLR.


What is the valuation status for SMLR stock?

ChartMill assigns a valuation rating of 4 / 10 to SEMLER SCIENTIFIC INC (SMLR). This can be considered as Fairly Valued.


How profitable is SEMLER SCIENTIFIC INC (SMLR) stock?

SEMLER SCIENTIFIC INC (SMLR) has a profitability rating of 6 / 10.


What is the valuation of SEMLER SCIENTIFIC INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SEMLER SCIENTIFIC INC (SMLR) is 2.26 and the Price/Book (PB) ratio is 0.65.